<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:46:46Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6797055" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6797055</identifier>
        <datestamp>2019-11-07</datestamp>
        <setSpec>jcem</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Clin Endocrinol Metab</journal-id>
              <journal-id journal-id-type="iso-abbrev">J. Clin. Endocrinol. Metab</journal-id>
              <journal-id journal-id-type="publisher-id">jcem</journal-id>
              <journal-title-group>
                <journal-title>The Journal of Clinical Endocrinology and Metabolism</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0021-972X</issn>
              <issn pub-type="epub">1945-7197</issn>
              <publisher>
                <publisher-name>Endocrine Society</publisher-name>
                <publisher-loc>Washington, DC</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6797055</article-id>
              <article-id pub-id-type="pmcid">PMC6797055</article-id>
              <article-id pub-id-type="pmc-uid">6797055</article-id>
              <article-id pub-id-type="pmid">31199458</article-id>
              <article-id pub-id-type="publisher-id">201900207</article-id>
              <article-id pub-id-type="doi">10.1210/jc.2019-00207</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Clinical Research Articles</subject>
                  <subj-group subj-group-type="category-toc-heading">
                    <subject>Parathyroid, Bone, and Mineral Metabolism</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Differential Effects of Oral Boluses of Vitamin D<sub>2</sub> vs Vitamin D<sub>3</sub> on Vitamin D Metabolism: A Randomized Controlled Trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5387-1721</contrib-id>
                  <name>
                    <surname>Martineau</surname>
                    <given-names>Adrian R</given-names>
                  </name>
                  <!--<email>a.martineau@qmul.ac.uk</email>-->
                  <xref ref-type="aff" rid="aff1">1</xref>
                  <xref ref-type="corresp" rid="c1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Thummel</surname>
                    <given-names>Kenneth E</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Zhican</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jolliffe</surname>
                    <given-names>David A</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Boucher</surname>
                    <given-names>Barbara J</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Griffin</surname>
                    <given-names>Simon J</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">3</xref>
                  <xref ref-type="aff" rid="aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Forouhi</surname>
                    <given-names>Nita G</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">3</xref>
                  <xref ref-type="author-notes" rid="fn1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hitman</surname>
                    <given-names>Graham A</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                  <xref ref-type="author-notes" rid="fn1"/>
                </contrib>
              </contrib-group>
              <aff id="aff1"><label>1</label><institution>Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London</institution>, London, <country country="GB">United Kingdom</country></aff>
              <aff id="aff2"><label>2</label><institution>Department of Pharmaceutics, University of Washington</institution>, Seattle, Washington</aff>
              <aff id="aff3"><label>3</label><institution>Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine</institution>, Cambridge, <country country="GB">United Kingdom</country></aff>
              <aff id="aff4"><label>4</label><institution>Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine</institution>, Cambridge, <country country="GB">United Kingdom</country></aff>
              <author-notes>
                <corresp id="c1"><bold><italic>Correspondence and Reprint Requests</italic></bold>: Adrian R. Martineau, PhD, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 58 Turner Street, London E1 2AB, United Kingdom. E-mail: <email>a.martineau@qmul.ac.uk</email>.</corresp>
                <fn id="fn1" fn-type="equal">
                  <p>N.G.F. and G.A.H. contributed equally to this study.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="collection">
                <month>12</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="epub" iso-8601-date="2019-06-14">
                <day>14</day>
                <month>6</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>14</day>
                <month>6</month>
                <year>2019</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
              <volume>104</volume>
              <issue>12</issue>
              <fpage>5831</fpage>
              <lpage>5839</lpage>
              <history>
                <date date-type="received">
                  <day>26</day>
                  <month>1</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>07</day>
                  <month>6</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright © 2019 Endocrine Society</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license license-type="cc-by" xlink:href="https://creativecommons.org/licenses/by/4.0/">
                  <license-p>This article has been published under the terms of the Creative Commons Attribution License (CC BY; <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is retained by the author(s).</license-p>
                </license>
              </permissions>
              <self-uri xlink:href="jc.2019-00207.pdf"/>
              <abstract>
                <title>Abstract</title>
                <sec id="s1">
                  <title>Context</title>
                  <p>Vitamin D<sub>2</sub> and vitamin D<sub>3</sub> have been hypothesized to exert differential effects on vitamin D metabolism.</p>
                </sec>
                <sec id="s2">
                  <title>Objective</title>
                  <p>To compare the influence of administering vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> on metabolism of vitamin D<sub>3</sub>.</p>
                </sec>
                <sec id="s3">
                  <title>Methods</title>
                  <p>We measured baseline and 4-month serum concentrations of vitamin D<sub>3,</sub> 25-hydroxyvitamin D<sub>3</sub> [25(OH)D<sub>3</sub>], 25-hydroxyvitamin D<sub>2</sub>, 24R,25-dihydroxyvitamin D<sub>3</sub> [24R,25(OH)<sub>2</sub>D<sub>3</sub>], 1<italic>α</italic>,25-dihydroxyvitamin D<sub>3</sub> [1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>], and 4<italic>β</italic>,25-dihydroxyvitamin D<sub>3</sub> [4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub>] in 52 adults randomized to receive a total of four oral bolus doses of 2.5 mg vitamin D<sub>2</sub> (n = 28) or vitamin D<sub>3</sub> (n = 24) over four months. Metabolite-to-parent compound ratios were calculated to estimate hydroxylase activity. Pairwise before vs after comparisons were made to evaluate effects of vitamin D<sub>2</sub> and vitamin D<sub>3</sub> on metabolism of vitamin D. Mean postsupplementation metabolite-to-parent ratios were then compared between groups.</p>
                </sec>
                <sec id="s4">
                  <title>Results</title>
                  <p>Vitamin D<sub>2</sub> was less effective than vitamin D<sub>3</sub> in elevating total serum 25(OH)D concentration. Vitamin D<sub>2</sub> suppressed mean four-month serum concentrations of 25(OH)D<sub>3</sub>, 24R,25(OH)<sub>2</sub>D<sub>3</sub>, 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>, and 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> and mean ratios of 25(OH)D<sub>3</sub> to D<sub>3</sub> and 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub>, while increasing the mean ratio of 24R,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub>. Vitamin D<sub>3</sub> increased mean four-month serum concentrations of 25(OH)D<sub>3</sub>, 24R,25(OH)<sub>2</sub>D<sub>3</sub>, 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>, and 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> and the mean ratio of 24R,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub>. Participants receiving vitamin D<sub>2</sub> had lower mean postsupplementation ratios of 25(OH)D<sub>3</sub> to vitamin D<sub>3</sub> and 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> than those receiving vitamin D<sub>3</sub>. Mean postsupplementation ratios of 24R,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> and 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> did not differ between groups.</p>
                </sec>
                <sec id="s5">
                  <title>Conclusions</title>
                  <p>Bolus-dose vitamin D<sub>2</sub> is less effective than bolus-dose vitamin D<sub>3</sub> in elevating total serum 25(OH)D concentration. Administration of vitamin D<sub>2</sub> reduces 25-hydroxylation of vitamin D<sub>3</sub> and 1-<italic>α</italic> hydroxylation of 25(OH)D<sub>3</sub>, while increasing 24R-hydroxylation of 25(OH)D<sub>3</sub>.</p>
                </sec>
              </abstract>
              <abstract abstract-type="teaser">
                <p>Data from this randomized controlled trial show that vitamin D<sub>2</sub> reduces 25-hydroxylation of vitamin D<sub>3</sub> and 1-<italic>α</italic> hydroxylation of 25(OH)D<sub>3</sub>, and increases 24R-hydroxylation of 25(OH)D<sub>3</sub>.</p>
              </abstract>
              <funding-group>
                <award-group award-type="grant">
                  <funding-source>
                    <named-content content-type="funder-name">Medical Research Council</named-content>
                    <named-content content-type="funder-identifier">10.13039/501100000265</named-content>
                  </funding-source>
                  <award-id>MC_UP_A100_1003</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <named-content content-type="funder-name">National Institutes of Health</named-content>
                    <named-content content-type="funder-identifier">10.13039/100000002</named-content>
                  </funding-source>
                  <award-id>R01 GM63666</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <named-content content-type="funder-name">Tower Hamlets Primary Care NHS Trust and East London CLRN</named-content>
                  </funding-source>
                  <award-id>GAH1</award-id>
                </award-group>
              </funding-group>
              <counts>
                <page-count count="9"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <p>Vitamin D has two forms: ergocalciferol (vitamin D<sub>2</sub>) is synthesized <italic>via</italic> UV irradiation of ergosterol, a steroid found in fungi and some plants, whereas cholecalciferol (vitamin D<sub>3</sub>) is synthesized via UV irradiation of 7-dehydrocholesterol to previtamin D<sub>3</sub>, followed by a thermal isomerization step. In humans, the source of vitamin D<sub>3</sub> may be endogenous (<italic>i.e.,</italic> obtained via cutaneous synthesis) or exogenous (<italic>i.e.,</italic> ingested in foods or supplements), whereas vitamin D<sub>2</sub> is only available from exogenous sources. Vitamin D<sub>2</sub> and vitamin D<sub>3</sub> are structurally distinct: the side chain of vitamin D<sub>2</sub> contains a double bond between carbons 22 and 23 and a methyl group on carbon 24, both of which are absent from the side chain of vitamin D<sub>3</sub>. The two forms also have differing pharmacokinetics: of 14 publications comparing effects of vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> (<xref rid="bib1" ref-type="bibr">1</xref>–<xref rid="bib14" ref-type="bibr">14</xref>), all but three (<xref rid="bib12" ref-type="bibr">12</xref>–<xref rid="bib14" ref-type="bibr">14</xref>) reported that vitamin D<sub>2</sub> was less effective than vitamin D<sub>3</sub> in elevating total 25(OH)D levels. A meta-analysis of data from seven of these studies found that this effect was only statistically significant when vitamin D was administered using intermittent bolus dosing, as opposed to daily administration (<xref rid="bib15" ref-type="bibr">15</xref>). 25-hydroxyvitamin D<sub>3</sub> [25(OH)D<sub>3</sub>] subsequently undergoes a second hydroxylation step to form the active vitamin D metabolite 1<italic>α</italic>,25-dihydroxyvitamin D<sub>3</sub> [1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>] or the inactive metabolites 24R,25-dihydroxyvitamin D<sub>3</sub> [24R,25(OH)<sub>2</sub>D<sub>3</sub>] and 4<italic>β</italic>,25-dihydroxyvitamin D [4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub>; <xref ref-type="fig" rid="fig1">Fig. 1</xref>]. It also undergoes conjugation to circulating inactive sulfate and glucuronide metabolites that may be recycled back to 25(OH)D<sub>3</sub> rather than excreted (<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>).</p>
            <fig id="fig1" orientation="portrait" position="float">
              <label>Figure 1.</label>
              <caption>
                <p>Vitamin D<sub>3</sub> oxidation pathways. The monohydroxylated and dihydroxylated metabolites investigated in the current study are shown, with the cytochrome P450 enzymes catalyzing each conversion in capitals.</p>
              </caption>
              <graphic xlink:href="jc.2019-00207f1"/>
            </fig>
            <p>Administration of vitamin D<sub>2</sub> has been reported to reduce circulating concentrations of 25(OH)D<sub>3</sub> in eight studies (<xref rid="bib1" ref-type="bibr">1</xref>–<xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib11" ref-type="bibr">11</xref>); a ninth study reports a nonstatistically significant trend in the same direction (<xref rid="bib12" ref-type="bibr">12</xref>). These observations have led investigators to speculate that vitamin D<sub>2</sub> may influence metabolism of vitamin D<sub>3</sub>. In keeping with this hypothesis, a recent study reported that administration of vitamin D<sub>2</sub> increases the ratio of 24R,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> in the circulation and decreases the ratio of 1<italic>α</italic>,25[OH]<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub>, findings taken to indicate that vitamin D<sub>2</sub> induces 24R-hydroxylation and suppresses 1<italic>α</italic>-hydroxylation of 25(OH)D<sub>3</sub> (<xref rid="bib18" ref-type="bibr">18</xref>). However, it is not yet known if these effects are vitamin D<sub>2</sub>-specific, because administration of vitamin D<sub>3</sub> also influences the rate of conversion of parent vitamin D<sub>3</sub> to its hydroxylated metabolites (<xref rid="bib19" ref-type="bibr">19</xref>). Moreover, the influence of administering vitamin D<sub>2</sub> on circulating concentrations of vitamin D<sub>3</sub> and 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> has yet to be determined.</p>
            <p>Studies making a head-to-head comparison of the influence of identical doses of vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> on circulating concentrations of vitamin D<sub>3</sub>, 25(OH)D<sub>3</sub> and its major dihydroxylated metabolites are needed to resolve these questions. An opportunity to conduct such an investigation recently arose in the context of a randomized controlled trial that we conducted in the United Kingdom to evaluate the effect of administration of four monthly oral doses of 2.5 mg vitamin D<sub>2</sub> vs the same dose of vitamin D<sub>3</sub> on glycated hemoglobin concentration among people at risk for type 2 diabetes mellitus (<xref rid="bib11" ref-type="bibr">11</xref>). We therefore determined concentrations of vitamin D<sub>3</sub>, 25(OH)D<sub>3</sub>, 24R,25(OH)<sub>2</sub>D<sub>3</sub>, 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>, and 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> in serum samples taken from a subset of trial participants before and after administration of vitamin D<sub>2</sub> vs vitamin D<sub>3</sub>, and calculated the change in postsupplementation metabolite-to-parent ratios to gain insight into the relative effects of vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> on the activity of enzymes catalyzing 25-hydroxylation of vitamin D<sub>3</sub> and 1<italic>α</italic>-hydroxylation, 24R-hydroxylation, and 4<italic>β</italic>-hydroxylation of 25(OH)D<sub>3</sub>. We also measured concentrations of vitamin D<sub>2</sub> and 25(OH)D<sub>2</sub> in the same samples and compared the influence of vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> on 25-hydroxylation of vitamin D<sub>2</sub>.</p>
            <sec sec-type="methods" id="s6">
              <title>Methods</title>
              <sec id="s7">
                <title>Trial design and participants</title>
                <p>As previously described, we conducted a double-blind, randomized placebo-controlled trial that enrolled a total of 340 men and women aged 30 to 75 years who had been identified as being at increased risk of developing type 2 diabetes mellitus in London and Cambridge, United Kingdom (<xref rid="bib11" ref-type="bibr">11</xref>). Full details of inclusion and exclusion criteria are described in the published protocol (<xref rid="bib20" ref-type="bibr">20</xref>). Eligible participants were randomly allocated to one of three groups on a 1:1:1 basis within four strata defined by age (30 to 50 or 51 to 75 years) and sex, with a block size of six within each stratum. One group received four monthly oral bolus doses of 2.5 mg vitamin D<sub>2</sub>: each dose was presented as 5 mL Sterogyl solution (Desma Pharma, Paris, France) containing 0.5 mg vitamin D<sub>2</sub> per milliliter in ethanol. The second group received four monthly oral bolus doses of 2.5 mg vitamin D<sub>3</sub>: each dose was presented as 5 mL Vigantol oil (Merck Serono, Darmstadt, Germany) containing 0.5 mg vitamin D<sub>3</sub> per milliliter in Miglyol oil (Caesar &amp; Loretz, Hilden, Germany). The third group received four monthly oral doses of placebo (Miglyol oil). The order of treatments within each block was determined by a computer-generated pseudo-random sequence, generated by the study medication manufacturer (Nova Laboratories, Leicester, UK). Neither the participants, the investigators, nor the laboratory staff knew the treatment allocation. Each participant was followed-up for a total of four months from their first visit; serum samples were collected at baseline and at the end of the study. Baseline and four-month serum samples taken from a subset of 28 participants and allocated to vitamin D<sub>2</sub> and 25 participants allocated to vitamin D<sub>3</sub> were sent for determination of concentrations of vitamin D<sub>3</sub> and its metabolites as detailed below. The subset of participants contributing samples to the current study were selected on the basis that they were all recruited in London; that they had each received four directly observed doses of vitamin D<sub>2</sub> or vitamin D<sub>3</sub>; and that they were the 28 samples in each group having the greatest volume of serum available at both baseline and four-month follow-up to be sent for further analysis. For the vitamin D<sub>3</sub> group, only 25 samples had sufficient sample volume for analysis. Ethical approval for the trial was provided by the Charing Cross Medical Ethics Committee (ref 09/H0711/85) and the Cambridge Local Research Ethics Committee (ref 04/Q0108/19), and written informed consent was obtained from all participants. The trial was registered under the numbers EudraCT 2009-011264-11 and ISRCTN86515510 on 23 October 2009.</p>
              </sec>
              <sec id="s8">
                <title>Laboratory assays</title>
                <p>Serum concentrations of vitamin D<sub>3</sub>, vitamin D<sub>2</sub>, 25(OH)D<sub>3</sub>, 25(OH)D<sub>2</sub>, 24R,25(OH)<sub>2</sub>D<sub>3</sub>, 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>, 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>2</sub>, and 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> were determined by liquid chromatography-tandem mass spectrometry in the Thummel Laboratory, Department of Pharmaceutics, University of Washington, Seattle, Washington, as previously described (<xref rid="bib21" ref-type="bibr">21</xref>). Lower limits of quantitation (LLOQ) were 0.23 nmol/L for vitamin D<sub>3</sub>, 0.15 nmol/L for vitamin D<sub>2</sub>, 0.50 nmol/L for 25(OH)D<sub>3</sub>, 0.24 nmol/L for 25(OH)D<sub>2</sub>, 0.14 nmol/L for 24R,25(OH)<sub>2</sub>D<sub>3</sub>, and 7.7 pmol/L for 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>, 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>2</sub> and 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub>. Where concentrations of a given analyte were less than the LLOQ, a value equal to the LLOQ divided by the √2 was imputed, as performed elsewhere (<xref rid="bib22" ref-type="bibr">22</xref>). Intraday and interday coefficients of variation were &lt;15% for all analytes, as previously reported (<xref rid="bib21" ref-type="bibr">21</xref>).</p>
              </sec>
              <sec id="s9">
                <title>Sample size and statistical analyses</title>
                <p>We estimated that paired before and after serum samples from 21 participants would need to be evaluated to have 90% power to detect a 15 nmol/L difference in 25(OH)D<sub>3</sub> concentration preadministration vs postadministration of vitamin D<sub>2</sub> with <italic>α</italic> = 0.05, based on a standard deviation for postsupplementation serum 25(OH)D<sub>3</sub> concentration of 20 nmol/L (<xref rid="bib11" ref-type="bibr">11</xref>). This sample size was inflated to 28 to allow for potential assay failure. Serum samples from a similar number of participants allocated to vitamin D<sub>3</sub> were also evaluated.</p>
                <p>Statistical analyses were conducted using GraphPad Prism version 6.04 (GraphPad Software Inc., La Jolla, CA) and STATA IC version 12 (StataCorp, College Station, TX). Intragroup differences in absolute concentrations of vitamin D<sub>3</sub> and its metabolites before vs after supplementation with vitamin D<sub>2</sub> or vitamin D<sub>3</sub> were evaluated using paired Student <italic>t</italic> tests. Intergroup differences in end-study values of these parameters were evaluated with linear regression, adjusting for baseline values. Mean differences are presented with 95% CI and <italic>P</italic> values, with statistical significance inferred where <italic>P</italic> values are less than 0.05.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="s10">
              <title>Results</title>
              <sec id="s11">
                <title>Participant enrollment and baseline characteristics</title>
                <p>A total of 340 adults were randomly assigned to receive supplementation with vitamin D<sub>2</sub> (n = 112) vs vitamin D<sub>3</sub> (n = 114) vs placebo (n = 114) between 2010 and 2012, of whom 285 (94 randomized to vitamin D<sub>2</sub> vs 99 randomized to vitamin D<sub>3</sub> vs 92 randomized to placebo) took all four doses of study medication and completed follow-up. For the current study, baseline and four-month serum samples collected from a subset of participants recruited in London who took four doses of vitamin D<sub>2</sub> (n = 28) or vitamin D<sub>3</sub> (n = 25) were sent for determination of concentrations of vitamin D and its metabolites (<xref ref-type="fig" rid="fig2">Fig. 2</xref>). Effects of the intervention on the primary outcome of the main trial, and on safety, are reported elsewhere (<xref rid="bib11" ref-type="bibr">11</xref>). The trial ended on the date of the final study visit of the last participant to be randomized. One participant selected for the substudy and randomly assigned to vitamin D<sub>3</sub> was found to have a high outlying baseline 25(OH)D<sub>2</sub> concentration (51.8 nmol/L) and was excluded from statistical analyses at a reviewer’s request. Baseline characteristics of participants whose serum samples contributed to the current study are presented in <xref rid="tbl1" ref-type="table">Table 1</xref>. Overall, mean age was 55.6 years (SD 10.0 years) and 21 of 52 (40.4%) participants were female. Baseline demographic and clinical characteristics, serum concentrations of vitamin D<sub>3</sub>, vitamin D<sub>2</sub> and their metabolites and metabolite-to-parent ratios were similar for those randomized to receive vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> where measurable; concentrations of 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>2</sub> were undetectable (&lt;7.7 pmol/L) in all samples.</p>
                <fig id="fig2" orientation="portrait" position="float">
                  <label>Figure 2.</label>
                  <caption>
                    <p>Trial profile.</p>
                  </caption>
                  <graphic xlink:href="jc.2019-00207f2"/>
                </fig>
                <table-wrap id="tbl1" orientation="portrait" position="float">
                  <label>Table 1.</label>
                  <caption>
                    <p>Participants’ Baseline Characteristics by Allocation</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <th rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">Characteristics</th>
                        <th align="center" rowspan="1" colspan="1">Vitamin D<sub>2</sub> (n=28)</th>
                        <th align="center" rowspan="1" colspan="1">Vitamin D<sub>3</sub> (n = 24)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">Sex</td>
                        <td align="center" rowspan="1" colspan="1">Female, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">10 (35.7)</td>
                        <td align="center" rowspan="1" colspan="1">11 (45.8)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">Male, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">18 (64.3)</td>
                        <td align="center" rowspan="1" colspan="1">13 (54.2)</td>
                      </tr>
                      <tr>
                        <td colspan="2" rowspan="1">Mean age, y (SD)</td>
                        <td align="center" rowspan="1" colspan="1">56.0 (10.8)</td>
                        <td align="center" rowspan="1" colspan="1">55.0 (9.1)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Ethnic origin</td>
                        <td align="center" rowspan="1" colspan="1">White, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">18 (64.3)</td>
                        <td align="center" rowspan="1" colspan="1">18 (75.0)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">Other, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">10<xref ref-type="table-fn" rid="tblfn1"><sup><italic>a</italic></sup></xref> (35.7)</td>
                        <td align="center" rowspan="1" colspan="1">6 (25.0)<xref ref-type="table-fn" rid="tblfn2"><sup><italic>b</italic></sup></xref></td>
                      </tr>
                      <tr>
                        <td rowspan="3" colspan="1">Total serum concentration of vitamin D and its metabolites<xref ref-type="table-fn" rid="tblfn3"><sup><italic>c</italic></sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">Mean total vitamin D, nmol/L (SD)<xref ref-type="table-fn" rid="tblfn4"><sup><italic>d</italic></sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">6.5 (6.7)</td>
                        <td align="center" rowspan="1" colspan="1">8.6 (8.5)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean total 25(OH)D, nmol/L (SD)<xref ref-type="table-fn" rid="tblfn5"><sup><italic>e</italic></sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">49.7 (32.3)</td>
                        <td align="center" rowspan="1" colspan="1">45.5 (25.0)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean total 25(OH)D-to-total vitamin D molar ratio (SD)</td>
                        <td align="center" rowspan="1" colspan="1">19.3 (27.5)</td>
                        <td align="center" rowspan="1" colspan="1">18.6 (22.4)</td>
                      </tr>
                      <tr>
                        <td rowspan="9" colspan="1">Serum concentration of vitamin D<sub>3</sub> and its metabolites</td>
                        <td align="center" rowspan="1" colspan="1">Mean vitamin D<sub>3</sub>, nmol/L (SD)</td>
                        <td align="center" rowspan="1" colspan="1">2.9 (3.3)</td>
                        <td align="center" rowspan="1" colspan="1">3.5 (4.2)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean 25(OH)D<sub>3</sub>, nmol/L (SD)</td>
                        <td align="center" rowspan="1" colspan="1">46.1 (32.4)</td>
                        <td align="center" rowspan="1" colspan="1">42.0 (24.7)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>, pmol/L (SD)</td>
                        <td align="center" rowspan="1" colspan="1">77.2 (46.0)</td>
                        <td align="center" rowspan="1" colspan="1">96.9 (55.1)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean 24R,25(OH)<sub>2</sub>D<sub>3</sub>, nmol/L (SD)</td>
                        <td align="center" rowspan="1" colspan="1">3.2 (2.7)</td>
                        <td align="center" rowspan="1" colspan="1">2.9 (1.8)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub>, pmol/L (SD)</td>
                        <td align="center" rowspan="1" colspan="1">126.4 (133.8)</td>
                        <td align="center" rowspan="1" colspan="1">97.1 (104.9)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean 25(OH)D<sub>3</sub>-to-vitamin D<sub>3</sub> molar ratio (SD)</td>
                        <td align="center" rowspan="1" colspan="1">39.0 (47.2)</td>
                        <td align="center" rowspan="1" colspan="1">34.1 (44.2)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean 24R,25(OH)<sub>2</sub>D<sub>3</sub>-to-25(OH)D<sub>3</sub> molar ratio (SD)</td>
                        <td align="center" rowspan="1" colspan="1">0.07 (0.03)</td>
                        <td align="center" rowspan="1" colspan="1">0.07 (0.04)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>-to-25(OH)D<sub>3</sub> molar ratio (SD)</td>
                        <td align="center" rowspan="1" colspan="1">0.0023 (0.0018)</td>
                        <td align="center" rowspan="1" colspan="1">0.0029 (0.0022)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub>-to-25(OH)D<sub>3</sub> molar ratio (SD)</td>
                        <td align="center" rowspan="1" colspan="1">0.0024 (0.0016)</td>
                        <td align="center" rowspan="1" colspan="1">0.0020 (0.0014)</td>
                      </tr>
                      <tr>
                        <td rowspan="4" colspan="1">Serum concentration of vitamin D<sub>2</sub> and its metabolites</td>
                        <td align="center" rowspan="1" colspan="1">Mean vitamin D<sub>2</sub>, nmol/L (SD)</td>
                        <td align="center" rowspan="1" colspan="1">3.6 (5.3)</td>
                        <td align="center" rowspan="1" colspan="1">5.1 (7.7)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean 25(OH)D<sub>2</sub>, nmol/L (SD)</td>
                        <td align="center" rowspan="1" colspan="1">3.5 (1.3)</td>
                        <td align="center" rowspan="1" colspan="1">3.5 (1.5)</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>2</sub>, pmol/L, (SD)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;7.7<xref ref-type="table-fn" rid="tblfn6"><sup><italic>f</italic></sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">&lt;7.7<xref ref-type="table-fn" rid="tblfn6"><sup><italic>f</italic></sup></xref></td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Mean 25(OH)D<sub>2</sub>-to-vitamin D<sub>2</sub> molar ratio (SD)</td>
                        <td align="center" rowspan="1" colspan="1">18.5 (17.2)</td>
                        <td align="center" rowspan="1" colspan="1">16.2 (19.5)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tblfn1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Of whom 6 were of black or black British ethnic origin and 4 were of Asian or Asian British ethnic origin.</p>
                    </fn>
                    <fn id="tblfn2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Of whom 5 were of Asian or Asian British ethnic origin and 1 was of black or black British ethnic origin.</p>
                    </fn>
                    <fn id="tblfn3">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p>Not calculated for 1,25-dihydroxyvitamin D (1,25-dihydroxyvitamin D<sub>2</sub> was undetectable in all) or 24,R,25-dihydroxyvitamin D/4<italic>β</italic>-dihydroxyvitamin D (neither 24,R,25-dihydroxyvitamin D<sub>2</sub> nor 4<italic>β</italic>-dihydroxyvitamin D<sub>2</sub> were measured).</p>
                    </fn>
                    <fn id="tblfn4">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p>Calculated by summing values for vitamin D<sub>2</sub> and vitamin D<sub>3.</sub></p>
                    </fn>
                    <fn id="tblfn5">
                      <label>
                        <sup>e</sup>
                      </label>
                      <p>Calculated by summing values for 25-hydroxyvitamin D<sub>2</sub> and 25-hydroxyvitamin D<sub>3.</sub></p>
                    </fn>
                    <fn id="tblfn6">
                      <label>
                        <sup>f</sup>
                      </label>
                      <p>1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>2</sub> undetectable in all; lower limit of quantification for this metabolite was 7.7 pmol/L.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="s12">
                <title>Influence of vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> on total 25(OH)D concentrations</title>
                <p>Both vitamin D<sub>2</sub> and vitamin D<sub>3</sub> elevated total 25(OH)D concentrations at follow-up: the mean increase in total 25(OH)D concentrations after administration of vitamin D<sub>2</sub> was 31.4 nmol/L (95% CI 21.5 to 41.2 nmol/L, <italic>P</italic> &lt; 0.001), and the corresponding increase in total 25(OH)D concentrations after administration of vitamin D<sub>3</sub> was 46.4 nmol/L (95% CI 33.7 to 59.0 nmol/L, <italic>P</italic> &lt; 0.001). The difference in the mean change in total 25(OH)D concentration at follow-up for participants randomized to vitamin D<sub>3</sub> vs vitamin D<sub>2</sub> was 13.0 nmol/L (95% CI -0.5 to 26.6 nmol/L, <italic>P</italic> = 0.06; <xref rid="tbl2" ref-type="table">Table 2;</xref><xref ref-type="fig" rid="fig3">Fig. 3</xref>). No difference in the ratio of total 25(OH)D to total parent vitamin D at follow-up was seen between participants randomized to vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> (<italic>P</italic> = 0.32).</p>
                <table-wrap id="tbl2" orientation="portrait" position="float">
                  <label>Table 2.</label>
                  <caption>
                    <p>Serum Concentrations of Vitamin D<sub>3</sub>, Vitamin D<sub>2</sub> and Their Metabolites After Administration of Vitamin D<sub>2</sub> vs Vitamin D<sub>3</sub></p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <th rowspan="2" colspan="1"/>
                        <th rowspan="2" align="center" colspan="1">Post-Vitamin D<sub>2</sub> (n = 28)</th>
                        <th rowspan="2" align="center" colspan="1">Post-Vitamin D<sub>3</sub> (n = 24)</th>
                        <th colspan="4" align="center" rowspan="1">Paired Analyses</th>
                        <th colspan="2" align="center" rowspan="1">Unpaired Analysis</th>
                      </tr>
                      <tr>
                        <th align="center" rowspan="1" colspan="1">Mean Difference, Post-Vitamin vs Pre-Vitamin D<sub>2</sub> (95% CI)</th>
                        <th align="center" rowspan="1" colspan="1">
                          <italic>P</italic>
                        </th>
                        <th align="center" rowspan="1" colspan="1">Mean Difference, Post-Vitamin vs Pre-Vitamin D<sub>3</sub> (95% CI)</th>
                        <th align="center" rowspan="1" colspan="1">
                          <italic>P</italic>
                        </th>
                        <th align="center" rowspan="1" colspan="1">Mean Difference, Post-Vitamin D<sub>3</sub> vs Post-Vitamin D<sub>2</sub> (95% CI)<xref ref-type="table-fn" rid="tblfn7"><sup><italic>a</italic></sup></xref></th>
                        <th align="center" rowspan="1" colspan="1">
                          <italic>P</italic>
                        </th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td colspan="9" rowspan="1">Total vitamin D and its metabolites<xref ref-type="table-fn" rid="tblfn8"><sup><italic>b</italic></sup></xref></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean total vitamin D, nmol/L (SD)<xref ref-type="table-fn" rid="tblfn9"><sup><italic>c</italic></sup></xref></td>
                        <td rowspan="1" colspan="1">7.4 (7.8)</td>
                        <td rowspan="1" colspan="1">6.8 (5.7)</td>
                        <td rowspan="1" colspan="1">0.9 (−3.1 to 5.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.65</td>
                        <td rowspan="1" colspan="1">−1.7 (−5.8 to 2.3)</td>
                        <td align="center" rowspan="1" colspan="1">0.39</td>
                        <td rowspan="1" colspan="1">−0.6 (−4.6 to 3.3)</td>
                        <td align="center" rowspan="1" colspan="1">0.75</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean total 25(OH)D, nmol/L (SD) <xref ref-type="table-fn" rid="tblfn10"><sup><italic>d</italic></sup></xref></td>
                        <td rowspan="1" colspan="1">81.0 (21.9)</td>
                        <td rowspan="1" colspan="1">91.9 (34.5)</td>
                        <td rowspan="1" colspan="1">31.4 (21.5 to 41.2)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                        <td rowspan="1" colspan="1">46.4 (33.7 to 59.0)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                        <td rowspan="1" colspan="1">13.0 (−0.5 to 26.6)</td>
                        <td align="center" rowspan="1" colspan="1">0.06</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean total 25(OH)D-to-total vitamin D molar ratio (SD)</td>
                        <td rowspan="1" colspan="1">27.8 (49.1)</td>
                        <td rowspan="1" colspan="1">17.6 (7.9)</td>
                        <td rowspan="1" colspan="1">8.5 (−13.9 to 31.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.44</td>
                        <td rowspan="1" colspan="1">−1.1 (−10.2 to 8.1)</td>
                        <td align="center" rowspan="1" colspan="1">0.81</td>
                        <td rowspan="1" colspan="1">−10.3 (−30.9 to 10.3)</td>
                        <td align="center" rowspan="1" colspan="1">0.32</td>
                      </tr>
                      <tr>
                        <td colspan="9" rowspan="1">Vitamin D<sub>3</sub> and its metabolites</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Mean vitamin D<sub>3</sub>, nmol/L (SD)</td>
                        <td rowspan="1" colspan="1">5.6 (7.3)</td>
                        <td rowspan="1" colspan="1">6.3 (5.5)</td>
                        <td rowspan="1" colspan="1">2.7 (−0.3 to 5.8)</td>
                        <td align="center" rowspan="1" colspan="1">0.07</td>
                        <td rowspan="1" colspan="1">2.8 (0.3 to 5.3)</td>
                        <td align="center" rowspan="1" colspan="1">0.03</td>
                        <td rowspan="1" colspan="1">0.5 (−3.2 to 4.1)</td>
                        <td align="center" rowspan="1" colspan="1">0.80</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean 25(OH)D<sub>3</sub>, nmol/L (SD)</td>
                        <td rowspan="1" colspan="1">26.2 (19.1)</td>
                        <td rowspan="1" colspan="1">88.2 (34.1)</td>
                        <td rowspan="1" colspan="1">−19.9 (−29.3 to −10.5)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                        <td rowspan="1" colspan="1">46.2 (33.3 to 59.2)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                        <td rowspan="1" colspan="1">64.0 (51.0 to 77.1)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean 24R,25(OH)<sub>2</sub>D<sub>3</sub>, nmol/L</td>
                        <td rowspan="1" colspan="1">2.0 (1.5)</td>
                        <td rowspan="1" colspan="1">7.7 (3.0)</td>
                        <td rowspan="1" colspan="1">−1.2 (−2.0 to −0.3)</td>
                        <td align="center" rowspan="1" colspan="1">0.007</td>
                        <td rowspan="1" colspan="1">4.8 (3.7 to 6.0)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                        <td rowspan="1" colspan="1">5.8 (4.7 to 7.0)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>, pmol/L</td>
                        <td rowspan="1" colspan="1">36.0 (50.5)</td>
                        <td rowspan="1" colspan="1">161.4 (95.4)</td>
                        <td rowspan="1" colspan="1">−41.1 (−63.8 to 18.5)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                        <td rowspan="1" colspan="1">64.5 (21.4 to 107.6)</td>
                        <td align="center" rowspan="1" colspan="1">0.005</td>
                        <td rowspan="1" colspan="1">119.7 (77.6 to 161.8)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub>, pmol/L</td>
                        <td rowspan="1" colspan="1">73.2 (81.9)</td>
                        <td rowspan="1" colspan="1">305.4 (438.6)</td>
                        <td rowspan="1" colspan="1">−53.2 (−99.2 to −7.2)</td>
                        <td align="center" rowspan="1" colspan="1">0.03</td>
                        <td rowspan="1" colspan="1">208.3 (40.7 to 375.9)</td>
                        <td align="center" rowspan="1" colspan="1">0.02</td>
                        <td rowspan="1" colspan="1">258.8 (98.0 to 419.7)</td>
                        <td align="center" rowspan="1" colspan="1">0.002</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean 25(OH)D<sub>3</sub>-to-vitamin D<sub>3</sub> molar ratio (SD)</td>
                        <td rowspan="1" colspan="1">9.3 (11.4)</td>
                        <td rowspan="1" colspan="1">18.2 (7.7)</td>
                        <td rowspan="1" colspan="1">−29.7 (−48.5 to −10.9)</td>
                        <td align="center" rowspan="1" colspan="1">0.003</td>
                        <td rowspan="1" colspan="1">−15.9 (−34.5 to 2.7)</td>
                        <td align="center" rowspan="1" colspan="1">0.09</td>
                        <td rowspan="1" colspan="1">9.0 (3.4 to 14.6)</td>
                        <td align="center" rowspan="1" colspan="1">0.002</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean 24R,25(OH)<sub>2</sub>D<sub>3</sub>-to-25(OH)D<sub>3</sub> molar ratio (SD)</td>
                        <td rowspan="1" colspan="1">0.0822 (0.0435)</td>
                        <td rowspan="1" colspan="1">0.0928 (0.0297)</td>
                        <td rowspan="1" colspan="1">0.0163 (0.0010 to 0.0315)</td>
                        <td align="center" rowspan="1" colspan="1">0.04</td>
                        <td rowspan="1" colspan="1">0.0214 (0.0069 to 0.0360)</td>
                        <td align="center" rowspan="1" colspan="1">0.006</td>
                        <td rowspan="1" colspan="1">0.0078 (−0.0114 to 0.0270)</td>
                        <td align="center" rowspan="1" colspan="1">0.42</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>-to-25(OH)D<sub>3</sub> molar ratio (SD)</td>
                        <td rowspan="1" colspan="1">0.0011 (0.0015)</td>
                        <td rowspan="1" colspan="1">0.0020 (0.0011)</td>
                        <td rowspan="1" colspan="1">−0.0012 (−0.0022 to −0.0002)</td>
                        <td align="center" rowspan="1" colspan="1">0.02</td>
                        <td rowspan="1" colspan="1">−0.0009 (−0.0020 to 0.0001)</td>
                        <td align="center" rowspan="1" colspan="1">0.06</td>
                        <td rowspan="1" colspan="1">0.0009 (0.0001 to 0.0017)</td>
                        <td align="center" rowspan="1" colspan="1">0.03</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub>-to-25(OH)D<sub>3</sub> molar ratio (SD)</td>
                        <td rowspan="1" colspan="1">0.0024 (0.0022)</td>
                        <td rowspan="1" colspan="1">0.0030 (0.0027)</td>
                        <td rowspan="1" colspan="1">0.0000 (−0.0009 to 0.0009)</td>
                        <td align="center" rowspan="1" colspan="1">0.97</td>
                        <td rowspan="1" colspan="1">0.0010 (−0.0001 to 0.0021)</td>
                        <td align="center" rowspan="1" colspan="1">0.06</td>
                        <td rowspan="1" colspan="1">0.0008 (−0.0006 to 0.0021)</td>
                        <td align="center" rowspan="1" colspan="1">0.25</td>
                      </tr>
                      <tr>
                        <td colspan="9" rowspan="1">Vitamin D<sub>2</sub> and its metabolites</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean vitamin D<sub>2</sub>, nmol/L (SD)</td>
                        <td rowspan="1" colspan="1">1.8 (1.1)</td>
                        <td rowspan="1" colspan="1">0.6 (0.8)</td>
                        <td rowspan="1" colspan="1">−1.8 (−4.0 to 0.3)</td>
                        <td align="center" rowspan="1" colspan="1">0.09</td>
                        <td rowspan="1" colspan="1">−4.5 (−7.7 to −1.3)</td>
                        <td align="center" rowspan="1" colspan="1">0.008</td>
                        <td rowspan="1" colspan="1">−1.2 (−1.8 to −0.6)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean 25(OH)D<sub>2</sub>, nmol/L (SD)</td>
                        <td rowspan="1" colspan="1">54.8 (12.9)</td>
                        <td rowspan="1" colspan="1">3.6 (1.5)</td>
                        <td rowspan="1" colspan="1">51.2 (46.2 to 56.3)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                        <td rowspan="1" colspan="1">0.1 (−0.5–0.7)</td>
                        <td align="center" rowspan="1" colspan="1">0.64</td>
                        <td rowspan="1" colspan="1">−51.1 (-56.5 to −45.7)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>2</sub>, pmol/L</td>
                        <td rowspan="1" colspan="1">&lt;7.7<sup><italic>e</italic></sup></td>
                        <td rowspan="1" colspan="1">&lt;7.7<xref ref-type="table-fn" rid="tblfn11"><sup><italic>e</italic></sup></xref></td>
                        <td rowspan="1" colspan="1">—</td>
                        <td align="center" rowspan="1" colspan="1">—</td>
                        <td rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">—</td>
                        <td rowspan="1" colspan="1">—</td>
                        <td align="center" rowspan="1" colspan="1">—</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mean 25(OH)D<sub>2</sub>-to-vitamin D<sub>2</sub> molar ratio, (SD)</td>
                        <td rowspan="1" colspan="1">111.0 (185.2)</td>
                        <td rowspan="1" colspan="1">24.6 (18.5)</td>
                        <td rowspan="1" colspan="1">92.5 (21.8 to 163.3)</td>
                        <td align="center" rowspan="1" colspan="1">0.01</td>
                        <td rowspan="1" colspan="1">8.4 (−0.8 to 17.7)</td>
                        <td align="center" rowspan="1" colspan="1">0.07</td>
                        <td rowspan="1" colspan="1">−83.7 (−160.0 to −7.4)</td>
                        <td align="center" rowspan="1" colspan="1">0.03</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tblfn7">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Adjusted for baseline value.</p>
                    </fn>
                    <fn id="tblfn8">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Not calculated for 1,25-dihydroxyvitamin D (1,25-dihydroxyvitamin D<sub>2</sub> was undetectable in all) or 24,R,25-dihydroxyvitamin D/4<italic>β</italic>-dihydroxyvitamin D (neither 24,R,25-dihydroxyvitamin D<sub>2</sub> nor 4<italic>β</italic>-dihydroxyvitamin D<sub>2</sub> were measured).</p>
                    </fn>
                    <fn id="tblfn9">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p>Calculated by summing values for vitamin D<sub>2</sub> and vitamin D<sub>3</sub>.</p>
                    </fn>
                    <fn id="tblfn10">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p>Calculated by summing values for 25-hydroxyvitamin D<sub>2</sub> and 25-hydroxyvitamin D<sub>3</sub>.</p>
                    </fn>
                    <fn id="tblfn11">
                      <label>
                        <sup>e</sup>
                      </label>
                      <p>1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>2</sub> undetectable in all; LLOQ for this metabolite was 7.7 pmol/L.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <fig id="fig3" orientation="portrait" position="float">
                  <label>Figure 3.</label>
                  <caption>
                    <p>Influence of oral administration of vitamin D<sub>3</sub> and vitamin D<sub>2</sub> on serum concentrations of (A) total 25(OH)D, (B) 25(OH)D<sub>3</sub>, (C) 25(OH)D<sub>2</sub>, and (D) 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub>. Baseline and 4-mo data are presented for 24 adults receiving four bolus doses of 2.5 mg vitamin D<sub>3</sub> at 0, 1, 2, and 3 mo postrandomization and 28 adults receiving an equivalent regimen of vitamin D<sub>2</sub>. Lines link data points from the same individual; <italic>P</italic> values for within-group comparisons before vs after supplementation are from paired Student <italic>t</italic> tests. <italic>P</italic> values for intergroup comparisons of postsupplementation values in participants randomized to vitamin D<sub>3</sub> vs vitamin D<sub>2</sub> are from linear regression with adjustment for baseline values.</p>
                  </caption>
                  <graphic xlink:href="jc.2019-00207f3"/>
                </fig>
              </sec>
              <sec id="s13">
                <title>Influence of vitamin D<sub>2</sub> on metabolism of vitamin D<sub>3</sub></title>
                <p>To characterize effects of vitamin D<sub>2</sub> on metabolism of D<sub>3</sub>, we conducted pairwise statistical analyses comparing circulating concentrations of vitamin D<sub>3</sub> and its metabolites in 28 individuals before vs after oral administration of four monthly doses of 2.5 mg vitamin D<sub>2</sub>. Results are presented in <xref rid="tbl2" ref-type="table">Table 2</xref>. Administration of vitamin D<sub>2</sub> had no statistically significant effect on serum concentrations of vitamin D<sub>3</sub> (<italic>P</italic> = 0.07), but it did reduce mean serum concentrations of 25(OH)D<sub>3</sub> (43.2% decrease, <italic>P</italic> &lt; 0.001; <xref ref-type="fig" rid="fig3">Fig. 3</xref>), 24R,25(OH)<sub>2</sub>D<sub>3</sub> (37.5% decrease, <italic>P</italic> = 0.007), 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub> (53.4% decrease, <italic>P</italic> &lt; 0.001; <xref ref-type="fig" rid="fig3">Fig. 3</xref>) and 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> (42.0% decrease, <italic>P</italic> = 0.03). Administration of vitamin D<sub>2</sub> reduced molar ratios of 25(OH)D<sub>3</sub> to vitamin D<sub>3</sub> (76.2% decrease, <italic>P</italic> = 0.003) and 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> (52.2% decrease, <italic>P</italic> = 0.02), but increased the molar ratio of 24R,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> (24.5% increase, <italic>P</italic> = 0.04). No statistically significant effect of vitamin D<sub>2</sub> on the molar ratio of 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> was seen (<italic>P</italic> = 0.97).</p>
              </sec>
              <sec id="s14">
                <title>Influence of vitamin D<sub>3</sub> on its own metabolism</title>
                <p>Having characterized the effects of vitamin D<sub>2</sub> on metabolism of vitamin D<sub>3</sub>, we proceeded to conduct a second set of pairwise before and after statistical analyses to evaluate the effects of vitamin D<sub>3</sub> on the same biochemical parameters in a separate group of 24 individuals who received four monthly doses of 2.5 mg vitamin D<sub>3</sub>. Results of these analyses (<xref rid="tbl2" ref-type="table">Table 2</xref>) show that administration of vitamin D<sub>3</sub> elevated serum concentrations of vitamin D<sub>3</sub> (80.0% increase, <italic>P</italic> = 0.03), 25(OH)D<sub>3</sub> (110.0% increase, <italic>P</italic> &lt; 0.001; <xref ref-type="fig" rid="fig3">Fig. 3</xref>), 24R,25(OH)<sub>2</sub>D<sub>3</sub> (165.5% increase, <italic>P</italic> &lt; 0.001), 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub> (66.6% increase, <italic>P</italic> = 0.005), and 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> (214.5% increase, <italic>P</italic> = 0.02). Administration of vitamin D<sub>3</sub> also increased the ratio of 24R,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> (32.6% increase, <italic>P</italic> = 0.006) but had no statistically significant effect on ratios of 25(OH)D<sub>3</sub> to vitamin D<sub>3</sub> (<italic>P</italic> = 0.09), 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> (<italic>P</italic> = 0.06), or 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> (<italic>P</italic> = 0.06).</p>
              </sec>
              <sec id="s15">
                <title>Comparing effects of vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> on metabolism of vitamin D<sub>3</sub></title>
                <p>To determine whether the two forms of vitamin D exerted different effects on metabolism of vitamin D<sub>3</sub>, we undertook unpaired statistical analyses comparing postsupplementation values of vitamin D<sub>3</sub> metabolite-to-parent ratios between individuals supplemented with vitamin D<sub>2</sub> vs vitamin D<sub>3</sub>, using linear regression with adjustment for baseline values. Results of these analyses (<xref rid="tbl2" ref-type="table">Table 2</xref>) reveal that participants receiving vitamin D<sub>2</sub> had lower mean postsupplementation ratios of 25(OH)D<sub>3</sub> to vitamin D<sub>3</sub> (<italic>P</italic> = 0.002) and 1<italic>α</italic>,25(OH)2D<sub>3</sub> to 25(OH)D<sub>3</sub> (<italic>P</italic> = 0.03) than those who received vitamin D<sub>3</sub>. No statistically significant difference in mean postsupplementation ratios of 24R,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> (<italic>P</italic> = 0.42) or 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> (<italic>P</italic> = 0.25) was seen between participants receiving vitamin D<sub>2</sub> vs vitamin D<sub>3</sub>.</p>
              </sec>
              <sec id="s16">
                <title>Influence of vitamin D<sub>3</sub> vs vitamin D<sub>2</sub> on metabolism of vitamin D<sub>2</sub></title>
                <p>Although the primary focus of our study was to compare the effects of vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> on metabolism of vitamin D<sub>3</sub>, limited data were also available to evaluate relative effects of the two forms of vitamin D on metabolism of vitamin D<sub>2</sub> (<xref rid="tbl2" ref-type="table">Table 2</xref>). Pairwise analyses revealed that administration of vitamin D<sub>2</sub> increased mean serum 25(OH)D<sub>2</sub> concentration (<italic>P</italic> &lt; 0.001; <xref ref-type="fig" rid="fig3">Fig. 3</xref>) and mean 25(OH)D<sub>2</sub>-to-D<sub>2</sub> molar ratio (<italic>P</italic> = 0.01), but had no statistically significant effect on mean serum concentration of vitamin D<sub>2</sub> itself (<italic>P</italic> = 0.09). By contrast, administration of vitamin D<sub>3</sub> reduced vitamin D<sub>2</sub> concentrations over time (<italic>P</italic> = 0.008) but did not influence 25(OH)D<sub>2</sub> concentrations (<italic>P</italic> = 0.64; <xref ref-type="fig" rid="fig3">Fig. 3</xref>) or 25(OH)D<sub>2</sub>-to-D<sub>2</sub> ratio (<italic>P</italic> = 0.07). Unpaired analysis comparing postsupplementation 25(OH)D<sub>2</sub>-to-D<sub>2</sub> ratios between individuals supplemented with vitamin D<sub>2</sub> vs vitamin D<sub>3</sub>, with adjustment for baseline values, showed that the mean postsupplementation ratio of 25(OH)D<sub>2</sub> to vitamin D<sub>2</sub> among participants receiving vitamin D<sub>2</sub> was higher than that of participants who received vitamin D<sub>3</sub> (<italic>P</italic> = 0.03).</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="s17">
              <title>Discussion</title>
              <p>To our knowledge, this is the first investigation to evaluate the influence of vitamin D<sub>2</sub> on circulating concentrations of parent vitamin D<sub>3</sub> and its dihydroxylated metabolite 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub> in addition to serum concentrations of 25(OH)D<sub>2</sub> and 25(OH)D<sub>3</sub>. We found that administration of vitamin D<sub>2</sub> exerted a greater inhibitory effect than administration of vitamin D<sub>3</sub> on mean ratios of 25(OH)D<sub>3</sub> to D<sub>3</sub> and 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> in the circulation. We also observed that vitamin D<sub>2</sub> and vitamin D<sub>3</sub> increased the mean 24R,25(OH)<sub>2</sub>D<sub>3</sub>-to-25(OH)D<sub>3</sub> ratio to a similar extent, and that neither form of vitamin D had a statistically significant effect on the mean serum 4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub>-to-25(OH)D<sub>3</sub> ratio. By contrast with findings of a recently published study (<xref rid="bib6" ref-type="bibr">6</xref>), we found that administration of vitamin D<sub>3</sub> did not suppress serum concentrations of 25(OH)D<sub>2</sub>, nor did it influence mean serum 25(OH)D<sub>2</sub>-to-vitamin D<sub>2</sub> ratio. Administration of vitamin D<sub>2</sub> resulted in an increase in the mean 25(OH)D<sub>2</sub>-to-D<sub>2</sub> ratio.</p>
              <p>Our findings are consistent with reports that administration of vitamin D<sub>2</sub> reduces serum concentrations of 25(OH)D<sub>3</sub> (<xref rid="bib1" ref-type="bibr">1</xref>–<xref rid="bib4" ref-type="bibr">4</xref>), and that this phenomenon is associated with an increase in the ratio of 24R,25(OH)<sub>2</sub>D<sub>3</sub> to 25(OH)D<sub>3</sub> and a decrease in the ratio of 1<italic>α</italic>,25(OH)2D<sub>3</sub> to 25(OH)D<sub>3</sub> in the circulation. Interestingly, serum 25(OH)D<sub>2</sub> concentrations were markedly elevated in all study participants receiving vitamin D<sub>2</sub>, consistent with induction of the vitamin D<sub>2</sub> 25-hydroxylation pathway, although there was an opposite effect on 25(OH)D<sub>3</sub> and rate of formation in the same treated individuals (<xref ref-type="fig" rid="fig3">Fig. 3</xref>), raising the possibility that different enzymes might catalyze 25-hydroxylation of the two forms of vitamin D. Alternatively, the decline of 25(OH)D<sub>3</sub> following administration of vitamin D<sub>2</sub> may reflect competition of vitamin D<sub>2</sub> for the same 25-hydroxylation pathway as vitamin D<sub>3</sub>. Although changes in metabolite-to-parent ratios may reflect alteration in rates of conversion of one metabolite to another, they could also be explained by removal of vitamin D and its metabolites from the circulation (<italic>e.g.,</italic> via direct excretion or disposition into depots such as adipose tissue and muscle). Further investigations to compare the effects of different forms of vitamin D on expression and activity of the enzymes responsible for metabolizing vitamin D<sub>3</sub> are needed to resolve the question of whether changes in metabolite-to-parent ratios truly reflect changes in activity of cytochrome P450 enzymes. Such studies would potentially require liver and renal biopsies: both are invasive procedures and their inclusion in a study protocol could raise issues relating to ethics and acceptability to participants.</p>
              <p>One aspect in which our findings differ from those of other investigators relates to the lack of detectable 1,25-dihydroxyvitamin D<sub>2</sub> at follow-up among participants receiving vitamin D<sub>2</sub> in our study. By contrast, Biancuzzo <italic>et al.</italic> reported that daily administration of 1,000 IU vitamin D<sub>2</sub> for 11 weeks induced a mean increase in serum 1,25(OH)<sub>2</sub>D<sub>2</sub> concentration of 5.2 pg/mL (13.5 pmol/L) (<xref rid="bib14" ref-type="bibr">14</xref>). This difference may reflect use of intermittent bolus dosing in the current study, which contrasts with the daily dosing regimen used by Biancuzzo <italic>et al.</italic></p>
              <p>Our findings provide insights into the differential effects of ergocalciferol and cholecalciferol on vitamin D metabolism, however, from the clinician’s perspective, a key question relates to relative effects of the two forms of vitamin D on total 25(OH)D levels, which reflect vitamin D status. Among substudy participants, the mean increase in total 25(OH)D for participants randomized to vitamin D<sub>2</sub> (n = 28) vs vitamin D<sub>3</sub> (n = 25) was 31.4 nmol/L vs 46.4 nmol/L, respectively (<italic>P</italic> for intergroup comparison = 0.06). This trend is in keeping with findings from the main trial, in which the difference in increase in total 25(OH)D for participants randomized to vitamin D<sub>2</sub> (n = 112) vs D<sub>3</sub> (n= 114; 31.2 vs 38.3 nmol/L increase, respectively) attained statistical significance (<italic>P</italic> = 0.03).</p>
              <p>Our study has several strengths. Participants randomized to vitamin D<sub>2</sub> vs D<sub>3</sub> were well matched with regard to baseline characteristics, and directly observed administration of vitamin D<sub>2</sub> and vitamin D<sub>3</sub> at identical doses via the same route allowed for a head-to-head comparison of their effects. Determination of concentrations of parent vitamin D<sub>2</sub> and D<sub>3</sub>, 25(OH)D<sub>2</sub>, 25(OH)D<sub>3</sub>, and its major dihydroxylated metabolites allowed us to compare effects of vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> on both the synthesis and the catabolism of 25(OH)D<sub>3</sub>. Moreover, we utilized the gold standard method (liquid chromatography-tandem mass spectrometry) to measure concentrations of vitamin D and its metabolites with high degrees of accuracy and sensitivity, avoiding issues of cross-reactivity between metabolites of vitamin D<sub>2</sub> and vitamin D<sub>3</sub> that may arise with immunoassays (<xref rid="bib23" ref-type="bibr">23</xref>).</p>
              <p>Our study also has some limitations. We measured concentrations of vitamin D metabolites at a single time point, one month after the fourth bolus dose was given; thus, we do not capture the pharmacokinetics of vitamin D metabolism at multiple points over the period of the dosing interval. In particular, conclusions relating to concentrations of parent vitamin D<sub>2</sub> and vitamin D<sub>3</sub> in the circulation should be guarded, because of their short half-life. Participants all had an elevated risk of type 2 diabetes mellitus: thus, our findings cannot necessarily be generalized to other groups. However, we have no specific reason to believe that effects of vitamin D<sub>2</sub> are likely to be different in this group compared with the general population. We did not measure concentrations of 1,24,25-trihydroxyvitamin D<sub>3</sub> or 24R,25(OH)<sub>2</sub>D<sub>2</sub>: this could have provided insights into the effects of vitamin D<sub>2</sub> vs vitamin D<sub>3</sub> on 24-hydroxylation of 1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub> and 25(OH)D<sub>2</sub>, respectively. Preparations of vitamin D<sub>2</sub> and vitamin D<sub>3</sub> were presented in different vehicles (alcohol vs oily solution, respectively), which could theoretically have impacted differently on absorption and/or metabolism. However, a study in schoolchildren comparing ethanol vs oil as a vehicle for a weekly oral dose of 14,000 IU vitamin D<sub>3</sub> showed no difference in the 25(OH)D response to supplementation between groups over eight weeks (<xref rid="bib24" ref-type="bibr">24</xref>), rendering this explanation for the findings in the current study unlikely.</p>
              <p>In conclusion, the current study confirms reports that vitamin D<sub>2</sub> is less effective than vitamin D<sub>3</sub> in elevating total 25(OH)D levels, and extends prior findings by showing that administration of vitamin D<sub>2</sub> reduces 25-hydroxylation of vitamin D<sub>3</sub> and 1-<italic>α</italic> hydroxylation of 25(OH)D<sub>3</sub> and increases 24R-hydroxylation of 25(OH)D<sub>3</sub>.</p>
            </sec>
          </body>
          <back>
            <ack id="a1">
              <title>Acknowledgments</title>
              <p>We acknowledge the contribution of all participants and general practices, members of the Trial Steering Committee [Prof. Andrew Morris (Chair), Dr. Ann Millward and Mrs. Yvonne Hunt), and members of the Data Monitoring Committee [Prof. Desmond Johnston (Chair), Prof. Garry John and Dr. Ian White]. The trial was jointly sponsored by Queen Mary University of London and the Medical Research Council Epidemiology Unit at Cambridge.</p>
              <p><italic><bold>Financial Support</bold></italic>: Tower Hamlets Primary Care National Health Service Trust; East London Comprehensive Local Research Network; United Kingdom Medical Research Council (MC_UP_A100_1003, MC_U106179474, MC_UU_12015/5 and MC_UU_12015/4); United Kingdom National Institute for Health Research (IS-BRC-1215-20014); US National Institutes of Health (R01 GM63666).</p>
              <p><bold><italic>Clinical Trial Registration:</italic></bold> EudraCT 2009-011264-11 and ISRCTN86515510 (registered 23 October 2009).</p>
              <p><bold><italic>Author Contributions:</italic></bold> G.A.H., N.G.F., B.J.B., S.J.G., and A.R.M. contributed to design of the main trial, for which G.A.H. was Chief Investigator and N.G.F. was lead investigator. A.R.M., D.A.J., and K.E.T. had the idea for the substudy presented in this manuscript. Z.W. and K.E.T. developed and ran laboratory assays. A.R.M. analyzed the data and wrote the first draft of the manuscript; all other authors critically reviewed it and approved the final version.</p>
              <sec id="s18">
                <title>Additional Information</title>
                <p><bold><italic>Disclosure Summary:</italic></bold> The authors have nothing to disclose.</p>
                <p><bold><italic>Data Availability:</italic></bold> Restrictions apply to the availability of data generated or analyzed during this study to preserve patient confidentiality or because they were used under license. The corresponding author will on request detail the restrictions and any conditions under which access to some data may be provided.</p>
              </sec>
            </ack>
            <glossary>
              <def-list list-content="abbreviations">
                <title>Abbreviations:</title>
                <def-item>
                  <term id="G1">1<italic>α</italic>,25(OH)<sub>2</sub>D<sub>3</sub></term>
                  <def>
                    <p>1<italic>α</italic>,25-dihydroxyvitamin D<sub>3</sub></p>
                  </def>
                </def-item>
                <def-item>
                  <term id="G2">4<italic>β</italic>,25(OH)<sub>2</sub>D<sub>3</sub></term>
                  <def>
                    <p>4<italic>β</italic>,25-dihydroxyvitamin D<sub>3</sub></p>
                  </def>
                </def-item>
                <def-item>
                  <term id="G3">24R,25(OH)<sub>2</sub>D<sub>3</sub></term>
                  <def>
                    <p>24R,25-dihydroxyvitamin D<sub>3</sub></p>
                  </def>
                </def-item>
                <def-item>
                  <term id="G4">25(OH)D</term>
                  <def>
                    <p>25-hydroxyvitamin D</p>
                  </def>
                </def-item>
                <def-item>
                  <term id="G5">25(OH)D<sub>3</sub></term>
                  <def>
                    <p>25-hydroxyvitamin D<sub>3</sub></p>
                  </def>
                </def-item>
                <def-item>
                  <term id="G6">LLOQ</term>
                  <def>
                    <p>lower limit of quantitation</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ref-list id="r1">
              <title>References and Notes</title>
              <ref id="bib1">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armas</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Hollis</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Heaney</surname><given-names>RP</given-names></name></person-group><article-title>Vitamin D2 is much less effective than vitamin D3 in humans</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2004</year>;<volume>89</volume>(<issue>11</issue>):<fpage>5387</fpage>–<lpage>5391</lpage>.<pub-id pub-id-type="pmid">15531486</pub-id></mixed-citation>
              </ref>
              <ref id="bib2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Binkley</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gemar</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Engelke</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gangnon</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ramamurthy</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Krueger</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Drezner</surname><given-names>MK</given-names></name></person-group><article-title>Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2011</year>;<volume>96</volume>(<issue>4</issue>):<fpage>981</fpage>–<lpage>988</lpage>.<pub-id pub-id-type="pmid">21289249</pub-id></mixed-citation>
              </ref>
              <ref id="bib3">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glendenning</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chew</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Seymour</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Gillett</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Goldswain</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Inderjeeth</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Vasikaran</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Taranto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Musk</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>WD</given-names></name></person-group><article-title>Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol</article-title>. <source>Bone</source>. <year>2009</year>;<volume>45</volume>(<issue>5</issue>):<fpage>870</fpage>–<lpage>875</lpage>.<pub-id pub-id-type="pmid">19631774</pub-id></mixed-citation>
              </ref>
              <ref id="bib4">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lehmann</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Hirche</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Stangl</surname><given-names>GI</given-names></name>, <name name-style="western"><surname>Hinz</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Westphal</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dierkes</surname><given-names>J</given-names></name></person-group><article-title>Bioavailability of vitamin D(2) and D(3) in healthy volunteers, a randomized placebo-controlled trial</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2013</year>;<volume>98</volume>(<issue>11</issue>):<fpage>4339</fpage>–<lpage>4345</lpage>.<pub-id pub-id-type="pmid">24001747</pub-id></mixed-citation>
              </ref>
              <ref id="bib5">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tjellesen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hummer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Christiansen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rødbro</surname><given-names>P</given-names></name></person-group><article-title>Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women</article-title>. <source>Bone Miner</source>. <year>1986</year>;<volume>1</volume>(<issue>5</issue>):<fpage>407</fpage>–<lpage>413</lpage>.<pub-id pub-id-type="pmid">2849489</pub-id></mixed-citation>
              </ref>
              <ref id="bib6">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hammami</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Abuhdeeb</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hammami</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yusuf</surname><given-names>A</given-names></name></person-group><article-title>Vitamin-D2 treatment-associated decrease in 25(OH)D3 level is a reciprocal phenomenon: a randomized controlled trial</article-title>. <source>BMC Endocr Disord</source>. <year>2019</year>;<volume>19</volume>:<fpage>8</fpage>.<pub-id pub-id-type="pmid">30658603</pub-id></mixed-citation>
              </ref>
              <ref id="bib7">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Logan</surname><given-names>VF</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Peddie</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Harper</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Houghton</surname><given-names>LA</given-names></name></person-group><article-title>Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months</article-title>. <source>Br J Nutr</source>. <year>2013</year>;<volume>109</volume>(<issue>6</issue>):<fpage>1082</fpage>–<lpage>1088</lpage>.<pub-id pub-id-type="pmid">23168298</pub-id></mixed-citation>
              </ref>
              <ref id="bib8">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trang</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Cole</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Pierratos</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Siu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vieth</surname><given-names>R</given-names></name></person-group><article-title>Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2</article-title>. <source>Am J Clin Nutr</source>. <year>1998</year>;<volume>68</volume>(<issue>4</issue>):<fpage>854</fpage>–<lpage>858</lpage>.<pub-id pub-id-type="pmid">9771862</pub-id></mixed-citation>
              </ref>
              <ref id="bib9">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heaney</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Recker</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Grote</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Horst</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Armas</surname><given-names>LA</given-names></name></person-group><article-title>Vitamin D(3) is more potent than vitamin D(2) in humans</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2011</year>;<volume>96</volume>(<issue>3</issue>):<fpage>E447</fpage>–<lpage>E452</lpage>.<pub-id pub-id-type="pmid">21177785</pub-id></mixed-citation>
              </ref>
              <ref id="bib10">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romagnoli</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mascia</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Cipriani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fassino</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Mazzei</surname><given-names>F</given-names></name>, <name name-style="western"><surname>D’Erasmo</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Carnevale</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Scillitani</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Minisola</surname><given-names>S</given-names></name></person-group><article-title>Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2008</year>;<volume>93</volume>(<issue>8</issue>):<fpage>3015</fpage>–<lpage>3020</lpage>.<pub-id pub-id-type="pmid">18492750</pub-id></mixed-citation>
              </ref>
              <ref id="bib11">
                <label>11.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forouhi</surname><given-names>NG</given-names></name>, <name name-style="western"><surname>Menon</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Mannan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Timms</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Martineau</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Rickard</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Boucher</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Chowdhury</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Griffiths</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Greenwald</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Griffin</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Hitman</surname><given-names>GA</given-names></name></person-group><article-title>Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial</article-title>. <source>Diabetes Obes Metab</source>. <year>2016</year>;<volume>18</volume>(<issue>4</issue>):<fpage>392</fpage>–<lpage>400</lpage>.<pub-id pub-id-type="pmid">26700109</pub-id></mixed-citation>
              </ref>
              <ref id="bib12">
                <label>12.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holick</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Biancuzzo</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>EK</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bibuld</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Reitz</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Salameh</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Ameri</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tannenbaum</surname><given-names>AD</given-names></name></person-group><article-title>Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2008</year>;<volume>93</volume>(<issue>3</issue>):<fpage>677</fpage>–<lpage>681</lpage>.<pub-id pub-id-type="pmid">18089691</pub-id></mixed-citation>
              </ref>
              <ref id="bib13">
                <label>13.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biancuzzo</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bibuld</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Winter</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>EK</given-names></name>, <name name-style="western"><surname>Ameri</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Reitz</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Salameh</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Holick</surname><given-names>MF</given-names></name></person-group><article-title>Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults</article-title>. <source>Am J Clin Nutr</source>. <year>2010</year>;<volume>91</volume>(<issue>6</issue>):<fpage>1621</fpage>–<lpage>1626</lpage>.<pub-id pub-id-type="pmid">20427729</pub-id></mixed-citation>
              </ref>
              <ref id="bib14">
                <label>14.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biancuzzo</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Reitz</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Travison</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Holick</surname><given-names>MF</given-names></name></person-group><article-title>Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2013</year>;<volume>98</volume>(<issue>3</issue>):<fpage>973</fpage>–<lpage>979</lpage>.<pub-id pub-id-type="pmid">23386645</pub-id></mixed-citation>
              </ref>
              <ref id="bib15">
                <label>15.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tripkovic</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lambert</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hart</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Bucca</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Penson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chope</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hyppönen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Berry</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vieth</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lanham-New</surname><given-names>S</given-names></name></person-group><article-title>Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis</article-title>. <source>Am J Clin Nutr</source>. <year>2012</year>;<volume>95</volume>(<issue>6</issue>):<fpage>1357</fpage>–<lpage>1364</lpage>.<pub-id pub-id-type="pmid">22552031</pub-id></mixed-citation>
              </ref>
              <ref id="bib16">
                <label>16.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hashizume</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Dickmann</surname><given-names>LZ</given-names></name>, <name name-style="western"><surname>Scian</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Koszewski</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Goff</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Horst</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Chaudhry</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Schuetz</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Thummel</surname><given-names>KE</given-names></name></person-group><article-title>Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability</article-title>. <source>Endocrinology</source>. <year>2014</year>;<volume>155</volume>(<issue>6</issue>):<fpage>2052</fpage>–<lpage>2063</lpage>.<pub-id pub-id-type="pmid">24641623</pub-id></mixed-citation>
              </ref>
              <ref id="bib17">
                <label>17.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Chapron</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Claw</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Foti</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Prasad</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Chapron</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Calamia</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chaudhry</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schuetz</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Horst</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Mao</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>de Boer</surname><given-names>IH</given-names></name>, <name name-style="western"><surname>Thornton</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Thummel</surname><given-names>KE</given-names></name></person-group><article-title>Polymorphic Human Sulfotransferase 2A1 Mediates the Formation of 25-Hydroxyvitamin D<sub>3</sub>-3-<italic>O</italic>-Sulfate, a Major Circulating Vitamin D Metabolite in Humans</article-title>. <source>Drug Metab Dispos</source>. <year>2018</year>;<volume>46</volume>(<issue>4</issue>):<fpage>367</fpage>–<lpage>379</lpage>.<pub-id pub-id-type="pmid">29343609</pub-id></mixed-citation>
              </ref>
              <ref id="bib18">
                <label>18.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Batacchi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Robinson-Cohen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hoofnagle</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Isakova</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kestenbaum</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>de Boer</surname><given-names>IH</given-names></name></person-group><article-title>Effects of vitamin D<sub>2</sub> supplementation on vitamin D<sub>3</sub> metabolism in health and CKD</article-title>. <source>Clin J Am Soc Nephrol</source>. <year>2017</year>;<volume>12</volume>(<issue>9</issue>):<fpage>1498</fpage>–<lpage>1506</lpage>.<pub-id pub-id-type="pmid">28768705</pub-id></mixed-citation>
              </ref>
              <ref id="bib19">
                <label>19.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heaney</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Armas</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Shary</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>NH</given-names></name>, <name name-style="western"><surname>Binkley</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hollis</surname><given-names>BW</given-names></name></person-group><article-title>25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions</article-title>. <source>Am J Clin Nutr</source>. <year>2008</year>;<volume>87</volume>(<issue>6</issue>):<fpage>1738</fpage>–<lpage>1742</lpage>.<pub-id pub-id-type="pmid">18541563</pub-id></mixed-citation>
              </ref>
              <ref id="bib20">
                <label>20.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Menon</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Rickard</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Mannan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Timms</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Martineau</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Boucher</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Chowdhury</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Griffiths</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Griffin</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Hitman</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Forouhi</surname><given-names>NG</given-names></name></person-group><article-title>The effects of vitamin D<sub>2</sub> or D<sub>3</sub> supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trial</article-title>. <source>BMC Public Health</source>. <year>2013</year>;<volume>13</volume>:<fpage>999</fpage>.<pub-id pub-id-type="pmid">24152375</pub-id></mixed-citation>
              </ref>
              <ref id="bib21">
                <label>21.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Senn</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kalhorn</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>XE</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Hebert</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Thummel</surname><given-names>KE</given-names></name></person-group><article-title>Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry</article-title>. <source>Anal Biochem</source>. <year>2011</year>;<volume>418</volume>(<issue>1</issue>):<fpage>126</fpage>–<lpage>133</lpage>.<pub-id pub-id-type="pmid">21784054</pub-id></mixed-citation>
              </ref>
              <ref id="bib22">
                <label>22.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganmaa</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Khudyakov</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Buyanjargal</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Jargalsaikhan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Baigal</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Munkhjargal</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Yansan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bolormaa</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lkhagvasuren</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sempos</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Bromage</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Ochirbat</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gunchin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Martineau</surname><given-names>AR</given-names></name></person-group><article-title>Prevalence and determinants of QuantiFERON-diagnosed tuberculosis infection in 9810 Mongolian schoolchildren</article-title>. <source>Clin Infect Dis</source>. <year>2019</year>;<volume>69</volume>(<issue>5</issue>):<fpage>813</fpage>–<lpage>819</lpage>.<pub-id pub-id-type="pmid">30481273</pub-id></mixed-citation>
              </ref>
              <ref id="bib23">
                <label>23.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Goff</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Peeters</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Crine</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lukas</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Souberbielle</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Cavalier</surname><given-names>E</given-names></name></person-group><article-title>Evaluation of the cross-reactivity of 25-hydroxyvitamin D2 on seven commercial immunoassays on native samples</article-title>. <source>Clin Chem Lab Med</source>. <year>2012</year>;<volume>50</volume>(<issue>11</issue>):<fpage>2031</fpage>–<lpage>2032</lpage>.<pub-id pub-id-type="pmid">23096759</pub-id></mixed-citation>
              </ref>
              <ref id="bib24">
                <label>24.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maalouf</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nabulsi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vieth</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kimball</surname><given-names>S</given-names></name>, <name name-style="western"><surname>El-Rassi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mahfoud</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>El-Hajj Fuleihan</surname><given-names>G</given-names></name></person-group><article-title>Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2008</year>;<volume>93</volume>(<issue>7</issue>):<fpage>2693</fpage>–<lpage>2701</lpage>.<pub-id pub-id-type="pmid">18445674</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
